Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis

Clinical trial NCT04943653 · UNKNOWN

Trial details

NCT number: NCT04943653
Sponsor: Seoul St. Mary's Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasms Paclitaxel Peritoneal Metastases

Start date: 2021-06-08
Primary completion: 2023-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.